Skip to main content
. 2016 Jun 7;24(2):117–128. doi: 10.3727/096504016X14612603423511

Figure 9.

Figure 9

Comparison of OS and PFS of patients treated by cilengitide. (a) Comparison of PFS; (b) comparison of OS. (A) Experimental group and (B) TEM + RAD group.